UpToDate
Official reprint from UpToDate®
www.uptodate.com ©2017 UpToDate, Inc. and/or its affiliates. All Rights Reserved.

Medline ® Abstract for Reference 139

of 'Treatment of relapsed or refractory multiple myeloma'

139
TI
Daratumumab monotherapy in patients with treatment-refractory multiple myeloma (SIRIUS): an open-label, randomised, phase 2 trial
AU
Lonial S,Weiss BM,Usmani SZ,Singhal S,Chari A,Bahlis NJ,Belch A,Krishnan A
SO
Lancet. 2016;
 
AD